Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.71 |
| ▸ | ACHE | P22303 | 8/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4687514 | 0.93 | EPHX1 (0.75) | EPHX1ACHENAAA | |
| SCHEMBL6286867 | 0.91 | EPHX1 (0.79) | EPHX1ACHENAAA | |
| SCHEMBL6287218 | 0.91 | EPHX1 (0.71) | EPHX1ACHENAAAMMP2MMP1 | |
| SCHEMBL9424811 | 0.91 | EPHX1 (0.68) | EPHX1ACHENAAA | |
| SCHEMBL320112 | 0.90 | EPHX1 (0.85) | EPHX1ACHEMMP2MMP1 | |
| SCHEMBL30786047 | 0.87 | EPHX1 (0.90) | EPHX1ACHEMMP2MMP1 | |
| SCHEMBL692078 | 0.87 | EPHX1 (0.52) | EPHX1 | |
| SCHEMBL4684710 | 0.86 | EPHX1 (0.83) | EPHX1ACHENAAA | |
| SCHEMBL4687820 | 0.86 | EPHX1 (0.83) | EPHX1ACHENAAA | |
| SCHEMBL27055529 | 0.86 | EPHX1 (0.83) | EPHX1ACHENAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7790923-B2 | Process for the production of phosphorous compounds | BASF Nederland B.V. and University of Amsterdam (US) | 2010-09-07 | — | — | US | disclosed |
| CN-101516897-A | Process for the production of phosphorous compounds | MEERN BV ENGELHARD DE (NL) | 2009-08-26 | — | — | CN | disclosed |
| US-20090082595-A1 | Process for the production of phosphorous compounds | ENGELHARD DE MEERN B.V. (NL) | 2009-03-26 | — | — | US | disclosed |
| US-7351829-B2 | Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use | DYOMICS GMBH (DE) | 2008-04-01 | — | — | US | disclosed |
| US-7351829-B2 | Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use | DYOMICS GMBH (DE) | 2008-04-01 | — | — | US | disclosed |
| EP-1816132-A1 | Process for the production of phosphorous compounds | ENGELHARD CORPORATION (US) | 2007-08-08 | — | — | EP | disclosed |
| US-6916854-B2 | Heat and/or light curable films or coatings comprising polyurethanes or polyureaurethane copolymers having storage stability, used as automobile paints | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20040097642-A1 | Unsaturated compounds containing carbamate terminal groups or urea terminal groups | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-20030045717-A1 | Compounds on the basis of 2 and 4-chromeenylidene-merocyaninese respectively, and their use | DYOMICS GMBH (DE) | 2003-03-06 | — | — | US | disclosed |
| US-5158808-A | Method of coating with a water borne composition | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1992-10-27 | — | — | US | disclosed |
| US-5039759-A | Water borne high solids coating compositions | TECHNOLOGY CORPORATION UNITED CARBIDE CHEMICALS AND PLASTICS (US) | 1991-08-13 | — | — | US | disclosed |
| EP-0212380-B1 | AQUEOUS HIGH SOLIDS COATING COMPOSITIONS | UNION CARBIDE CORPORATION (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0212380-A2 | Aqueous high solids coating compositions | UNION CARBIDE CORPORATION (US) | 1987-03-04 | — | — | EP | disclosed |
| EP-0211359-A1 | High solids coating compositions | UNION CARBIDE CORPORATION (US) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045717-A1 | Compounds on the basis of 2 and 4-chromeenylidene-merocyaninese respectively, and their use | HCCS, CRY2, XDH | EPHX1 2237/4885ACHE 403/4885NAAA 2649/4885 |
| US-20090082595-A1 | Process for the production of phosphorous compounds | TPMT, NUDT1, MTAP | EPHX1 2576/4885ACHE 1349/4885NAAA 67/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.